First Time Loading...

Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 19.62 HKD 1.03% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

591.6B
+7%
Revenue
Growth Rates:
1 Year
+11%
3 Years
+38%
5 Years
+77%
7 Years
+142%
10 Years
+294%
22.9B
+2%
Operating Income
Growth Rates:
1 Year
+8%
3 Years
+32%
5 Years
+59%
7 Years
+133%
10 Years
+333%
8.9B
+5%
Net Income
Growth Rates:
1 Year
+14%
3 Years
+45%
5 Years
+59%
7 Years
+103%
10 Years
+311%

Earnings Waterfall
Sinopharm Group Co Ltd

Revenue
591.6B CNY
Cost of Revenue
-542.6B CNY
Gross Profit
49B CNY
Operating Expenses
-26.1B CNY
Operating Income
22.9B CNY
Other Expenses
-14B CNY
Net Income
8.9B CNY

Income Statement
Sinopharm Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023
Revenue
Revenue
84 878
N/A
102 225
+20%
120 787
+18%
136 501
+13%
150 005
+10%
166 866
+11%
181 636
+9%
200 131
+10%
216 353
+8%
228 673
+6%
244 414
+7%
258 388
+6%
270 267
+5%
308 354
+14%
334 060
+8%
344 526
+3%
398 705
+16%
425 273
+7%
427 372
+0%
456 415
+7%
501 770
+10%
521 051
+4%
533 403
+2%
552 148
+4%
591 626
+7%
Gross Profit
Cost of Revenue
(77 802)
(93 870)
(110 899)
(125 514)
(138 147)
(153 488)
(166 724)
(183 803)
(198 742)
(209 953)
(224 559)
(237 717)
(248 927)
(282 305)
(304 441)
(313 298)
(362 759)
(387 741)
(390 084)
(416 091)
(458 101)
(477 001)
(488 282)
(504 713)
(542 579)
Gross Profit
7 076
N/A
8 355
+18%
9 888
+18%
10 987
+11%
11 858
+8%
13 379
+13%
14 911
+11%
16 328
+10%
17 610
+8%
18 720
+6%
19 855
+6%
20 671
+4%
21 339
+3%
26 049
+22%
29 619
+14%
31 228
+5%
35 946
+15%
37 531
+4%
37 288
-1%
40 323
+8%
43 669
+8%
44 051
+1%
45 121
+2%
47 434
+5%
49 047
+3%
Operating Income
Operating Expenses
(4 095)
(4 718)
(5 496)
(6 120)
(6 571)
(7 277)
(7 885)
(8 466)
(9 049)
(9 493)
(10 026)
(10 457)
(10 428)
(12 908)
(15 199)
(15 474)
(18 343)
(19 444)
(19 925)
(21 290)
(23 140)
(23 208)
(23 884)
(24 893)
(26 141)
Selling, General & Administrative
(4 194)
(4 888)
(5 713)
(6 337)
(6 766)
(7 416)
(8 181)
(8 670)
(9 245)
(9 737)
(10 262)
(10 729)
(10 835)
(12 277)
(15 588)
(14 762)
(18 785)
(18 472)
(20 509)
(20 329)
(23 718)
(22 102)
(24 464)
(23 791)
(26 836)
Depreciation & Amortization
0
0
0
0
0
(150)
0
0
0
0
0
0
0
(1 026)
0
(1 086)
0
(1 413)
0
(1 613)
0
(1 695)
0
(1 779)
0
Other Operating Expenses
99
169
217
219
196
289
297
204
196
244
236
272
408
394
390
374
443
441
584
652
578
589
580
676
695
Operating Income
2 981
N/A
3 636
+22%
4 392
+21%
4 869
+11%
5 288
+9%
6 102
+15%
7 025
+15%
7 862
+12%
8 562
+9%
9 227
+8%
9 829
+7%
10 214
+4%
10 911
+7%
13 140
+20%
14 420
+10%
15 754
+9%
17 603
+12%
18 087
+3%
17 363
-4%
19 034
+10%
20 528
+8%
20 843
+2%
21 236
+2%
22 541
+6%
22 906
+2%
Pre-Tax Income
Interest Income Expense
(288)
(509)
(755)
(987)
(1 116)
(1 406)
(1 653)
(1 859)
(1 818)
(1 692)
(1 565)
(1 512)
(1 440)
(1 922)
(2 587)
(2 743)
(3 265)
(3 981)
(3 634)
(3 054)
(3 099)
(3 202)
(3 265)
(3 823)
(3 412)
Non-Reccuring Items
0
0
7
5
(2)
3
11
13
14
52
166
146
23
219
0
(357)
(409)
(114)
(41)
(134)
(142)
(609)
(614)
(62)
(65)
Gain/Loss on Disposition of Assets
124
90
33
223
237
16
1
6
17
6
307
256
82
46
49
16
12
5
28
39
60
64
33
39
167
Total Other Income
(49)
(89)
(126)
(87)
(92)
(94)
(69)
(87)
(92)
(125)
(160)
(179)
(322)
(257)
(168)
(462)
(511)
(238)
(126)
(287)
(249)
(92)
(101)
(132)
(169)
Pre-Tax Income
2 768
N/A
3 127
+13%
3 551
+14%
4 022
+13%
4 314
+7%
4 621
+7%
5 316
+15%
5 935
+12%
6 684
+13%
7 469
+12%
8 577
+15%
8 925
+4%
9 253
+4%
11 227
+21%
11 713
+4%
12 208
+4%
13 430
+10%
13 760
+2%
13 591
-1%
15 598
+15%
17 098
+10%
17 003
-1%
17 290
+2%
18 564
+7%
19 426
+5%
Net Income
Tax Provision
(664)
(725)
(823)
(937)
(962)
(1 041)
(1 225)
(1 383)
(1 552)
(1 728)
(1 969)
(2 033)
(2 060)
(2 562)
(2 687)
(2 803)
(3 085)
(3 140)
(3 135)
(3 501)
(3 775)
(3 938)
(4 025)
(4 218)
(4 416)
Income from Continuing Operations
2 104
2 402
2 728
3 086
3 353
3 580
4 092
4 552
5 132
5 741
6 607
6 892
7 193
8 665
9 027
9 404
10 346
10 620
10 455
12 097
13 322
13 065
13 265
14 345
15 010
Income to Minority Interest
(749)
(842)
(993)
(1 106)
(1 180)
(1 330)
(1 528)
(1 677)
(1 809)
(1 969)
(2 213)
(2 244)
(2 310)
(3 089)
(3 418)
(3 569)
(4 213)
(4 368)
(4 282)
(4 910)
(5 448)
(5 306)
(5 395)
(5 820)
(6 074)
Net Income (Common)
1 355
N/A
1 560
+15%
1 735
+11%
1 979
+14%
2 172
+10%
2 250
+4%
2 563
+14%
2 875
+12%
3 323
+16%
3 772
+14%
4 394
+16%
4 647
+6%
4 883
+5%
5 576
+14%
5 606
+1%
5 836
+4%
6 130
+5%
6 251
+2%
6 174
-1%
7 187
+16%
7 874
+10%
7 759
-1%
7 870
+1%
8 526
+8%
8 936
+5%
EPS (Diluted)
0.59
N/A
0.66
+12%
0.72
+9%
0.82
+14%
0.88
+7%
0.89
+1%
1
+12%
1.11
+11%
1.2
+8%
1.36
+13%
1.59
+17%
1.68
+6%
1.77
+5%
1.88
+6%
1.88
N/A
1.96
+4%
2.06
+5%
2.11
+2%
1.99
-6%
2.31
+16%
2.53
+10%
2.49
-2%
2.52
+1%
2.73
+8%
2.87
+5%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.